Skip to main content
. 2017 Dec 8;12(12):e0187833. doi: 10.1371/journal.pone.0187833

Table 3. Parameters associated with the functional exercise capacity among the studied groups.

Control (n = 23) Sickle Cell Anemia NE (n = 21) Sickle Cell Anemia AE (n = 24) NE-AE p ANOVA p
Pre-6MWT heart rate (beats/min) 81.2±10.7 78.9±11.7 83.6±12.5 ns ns
Post-6MWT heart rate (beats/min) 102.1±16.6 93.6±15.9 95.8±16.4** ns 0.005
Pre-6MWT respiratory rate (breaths/min) 16.8±3.1 19.2±2.9* 20.8±4.8*** ns 0.005
Post-6MWT respiratory rate (breaths/min) 20.5±3.3 22.5±3.0 25.0±6.2** ns 0.005
Pre-6MWT systolic blood pressure (mm Hg) 113.9±13.5 124.8±15.5* 115.7±13.0 ns 0.05
Post-6MWT systolic blood pressure (mm Hg) 121.2±11.7 140.2±15.6**** 126.2±13.5 0.01 0.0001
Pre-6MWT diastolic blood pressure (mm Hg) 77.1±11.5 82.0±13.9** 70.3±12.0 0.01 0.01
Post-6MWT diastolic blood pressure (mm Hg) 84.9±10.3 87.0±10.5 74.5±14.2* 0.005 0.001
SpO2 (%)
Pre-6MWT
97.7±1. 5 96.0±2.5** 93.8±3.1**** 0.05 0.0001
SpO2 (%)
Post-6MWT
97.8±1.2 95.5±3.2** 93.2±3.8**** 0.05 0.0001

Data are means±SD. Sickle Cell Anemia NE = Patients with normal spirometric exams; Sickle Cell Anemia AE = Patients with altered spirometric exams; 6MWD: Six-minute walk distance; (%): predicted percentage. CF: Cardiac frequency. RR: Respiratory rate. SBP: Systolic blood pressure. DBP: Diastolic blood pressure. SpO2: Peripheral oxygen saturation. ns = not significant (p >0.05)

*p<0.05 related to control group

**p<0.01 related to control group

***p<0.001 related to control group

****p<0.0001 related to control group.